Incyte Reports 2015 Fourth-Quarter and Year-End Financial Results, Provides 2016 Financial Guidance and Updates Shareholders on Key Clinical Programs
Go back to Incyte Reports 2015 Fourth-Quarter and Year-End Financial Results, Provides 2016 Financial Guidance and Updates Shareholders on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 116.86 +3.05 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.81 | 52 Week High | $118.49 | |||
| Open | $114.18 | 52 Week Low | $55.00 | |||
| Day High | $118.69 | P/E | N/A | |||
| Day Low | $113.50 | EPS | $-0.56 | |||
| Volume | 2,632,597 | |||||
